Department of Error

Abstract

Terkelsen CJ, Freeman P, Dahl JS, et al. SAPIEN 3 versus Myval transcatheter heart valves for transcatheter aortic valve implantation (COMPARE-TAVI 1): a multicentre, randomised, non-inferiority trial. Lancet 2025; 405: 1362–72—In this Article, the last sentence in the Results section should read “At 1 year, patients treated with SAPIEN 3 THVs walked a median of 382 m (IQR 295–450) on the 6-min walk test, whereas patients treated with Myval THVs walked 383 m (300–450; p=0·43).” These corrections have been made to the online version as of June 19, 2025.